NCT07778277 · NOT YET RECRUITING
Personalized Sensory Stimulation: Urban and Rural Dementia Care
This trial is testing a combination of personalized gamma-frequency music stimulation and cognitive training for people with mild cognitive impairment or dementia. Researchers are comparing an active version of the device against a sham version to see whether the real stimulation improves brain function. It is being run across urban and rural care settings in Taiwan. This is a Phase NA study — meaning it is evaluating feasibility and practical deployment, not a standard drug efficacy trial.
You may qualify if
- Aged ≥ 60 years
- The score of MoCA between 10 to 25
You're excluded if
- Diagnosis of other psychiatric or neurological disorders, and those with a history of neurological or psychiatric disorders that may affect cognitive assessment or performance. For example (but not limited to): Parkinson's disease, schizophrenia, major depressive disorder, epilepsy, severe traumatic brain injury with loss of consciousness, and stroke.
- Drug, Nicotine or alcohol addictions
- Serious heart, liver or kidney disorders, and visual, auditory or motor impairments interfering with neuropsychological tests.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-08-21